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Summary 
Sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, plays a critical role in 
the orchestration of immune responses. S1P levels within the mammalian host are tightly 
regulated, in part through the activity of S1P lyase (S1PL) which catalyses its irreversible 
degradation. Herein we describe the identification and characterization of secreted S1PL 
orthologues encoded by the facultative intracellular bacteria Burkholderia pseudomallei and 
Burkholderia thailandensis. These bacterial orthologues exhibited S1PL enzymatic activity, 
functionally complemented an S1PL-deficient yeast strain, and conferred resistance to the 
antimicrobial sphingolipid D-erythro-sphingosine. We report that secretion of these bacterial 
S1PLs is pH-dependent, and is observed during intracellular infection. S1PL-deficient 
mutants displayed impaired intracellular replication in murine macrophages (associated with 
an inability to evade the maturing phagosome) and were significantly attenuated in murine 
and larval infection models. Furthermore, treatment of Burkholderia-infected macrophages 
with either S1P or a selective agonist of S1P receptor 1 enhanced bacterial colocalisation with 
LAMP-1 and reduced their intracellular survival. In summary, our studies confirm bacterial-
encoded S1PL as a critical virulence determinant of B. pseudomallei and B. thailandensis, 
further highlighting the pivotal role of S1P in host-pathogen interactions. In addition, our data 
suggest that S1P pathway modulators have potential for the treatment of intracellular 
infection.  
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Introduction 
Intracellular bacterial infections, including those caused by Mycobacterium tuberculosis, 
Salmonella typhi and Burkholderia pseudomallei, pose a major global health burden affecting 
tens of millions of people annually. The intracellular location provides protection against 
immune defences and antimicrobial therapy, with the result that such infections are often 
difficult to eradicate, and are frequently persistent or recurrent in nature. New therapeutic 
strategies are urgently required, the rational design of which demands a full appreciation of 
the mechanisms employed by intracellular bacteria to subvert the host cells in which they 
reside. Herein we focus on one such subversion strategy – the targeting of the host 
sphingosine-1-phosphate (S1P) axis. 
S1P is a bioactive sphingolipid metabolite implicated in numerous biological processes 
(Alvarez et al., 2007). In response to diverse stimuli, plasma membrane sphingolipids (e.g. 
sphingomyelin) can be readily metabolized to ceramide, and subsequently to sphingosine. 
Two sphingosine kinases (SphKs) phosphorylate sphingosine to generate S1P, levels of 
which are tightly regulated by balancing SphK activity with the activity of enzymes 
responsible for S1P dephosphorylation (S1P phosphatases; S1PP) or irreversible S1P 
degradation (S1P lyase; S1PL). The S1P pathway has been described as a “cellular rheostat 
that determines cell survival or death” (Alvarez et al., 2007), as whilst S1P promotes cell 
survival, its precursors (ceramide and sphingosine) and one of its degradation products 
(hexadecenal) promote apoptosis (Kumar et al., 2011). Moreover, the role of S1P extends 
beyond the regulation of cell survival. S1P activity has been extensively studied in the 
context of immune and inflammatory responses, where it plays roles in cellular 
differentiation and polarization, vascular integrity, trafficking and activity of immune cells, 
and cytokine/chemokine profiles (for review, see Spiegel and Milstien, 2011; Weigert et al., 
2009). S1P exerts such pleiotropic effects as it can function as an intracellular second 
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messenger as well as acting in an autocrine and/or paracrine manner to activate five distinct 
G protein-coupled cell surface receptors (S1PR1-5) (Alvarez et al., 2007). 
In the context of the innate immune response, S1P is a critical regulator of macrophage 
function, influencing phagosome-lysosome fusion by triggering the mobilisation of 
intracellular Ca2+ (Blom et al., 2005). Intracellular pathogens that preferentially target 
macrophages employ diverse strategies to circumvent their bactericidal activity, and 
disruption of S1P-mediated phagosome maturation is one such strategy. This is exemplified 
by M. tuberculosis, which inhibits the activation and phagosomal translocation of SphK, thus 
blocking the S1P-dependent increase in cytosolic Ca2+ and impairing phagosome maturation 
(Malik et al., 2003; Thompson et al., 2005). Similarly, Shigella flexneri has recently been 
reported to suppress the host inflammatory response by lowering S1P levels through the two 
branches of the S1P pathway; promoting the transcriptional upregulation of host genes 
encoding the S1P lyase and phosphatase enzymes and the parallel downregulation of SphK-
encoding genes (Kim et al., 2014). The molecular events that underlie SphK inhibition by M. 
tuberculosis and the host S1P pathway modulation by Shigella remain to be defined.  
To date, the only documented bacterial effector proven to target the host S1P pathway is an 
S1PL orthologue (LegS2) of Legionella pneumophila that is secreted by the Dot/Icm Type IV 
secretion system (Degtyar et al., 2009). This Legionella S1PL orthologue contributes to the 
restriction of L. pneumophila and the restraining of autophagy within infected macrophages, 
and also contributes to virulence within a murine pulmonary infection model (Abu Khweek et 
al., 2016; Rolando et al., 2016). In the course of our studies, we observed that Burkholderia 
pseudomallei and Burkholderia thailandensis, two closely-related facultative intracellular 
bacterial species, each encode two putative S1PL orthologues that are phylogenetically 
distinct from LegS2 of L. pneumophila. B. pseudomallei is the causative agent of melioidosis, 
an endemic disease in Southeast Asia and Northern Australia. Recent estimates put the global 
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burden of melioidosis at 165,000 cases per year worldwide, with mortality rates of up to 50 % 
(Limmathurotsakul et al., 2016). Central to the pathogenesis of B. pseudomallei is its ability 
to invade, survive and replicate in both phagocytic and non-phagocytic cells (Jones et al., 
1996). Whilst B. thailandensis is highly attenuated relative to B. pseudomallei, it displays a 
similar intracellular phenotype characterized by endosomal escape, intracellular replication 
and actin-based motility (Wand et al., 2011), and as such is a valuable model for studying the 
intracellular lifestyle of B. pseudomallei.  
Herein we report the characterization of the Burkholderia S1PL orthologues, demonstrating 
that they indeed possess S1PL activity and that they play a critical role in virulence that is 
distinct from that of LegS2 of Legionella. In doing so, our studies provide new insight into 
intracellular survival strategies employed by B. pseudomallei and further highlight the critical 
role of the S1P axis at the host-pathogen interface. In addition, through treatment of 
Burkholderia-infected macrophages with S1P receptor agonists, we demonstrate that specific 
modulators of the S1PR1-mediated pathway may represent a therapeutic strategy for the 
treatment of intracellular infections. 
 
Results 
Identification of Burkholderia-encoded sphingosine-1-phosphate lyases (S1PL) 
 
In the course of studies investigating bacterial enzymes involved in sphingolipid biosynthesis 
and metabolism (Raman et al., 2010), we identified putative S1PL-encoding genes within the 
genomes of B. pseudomallei and B. thailandensis. Using the Burkholderia genome database 
(Winsor et al., 2008) and B. pseudomallei K96243 and B. thailandensis E264 as 
representative strains, we identified two putative S1PLs in each species – encoded by 
BPSS2021 and BPSS2025 in B. pseudomallei K96243, and BTH_II0309 and BTH_II0311 in 
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B. thailandensis E264. Within each organism, genes encoding the two putative S1PLs are not 
co-located within an operon but are located within the same genomic region, with a high 
degree of synteny between the corresponding regions of each species (Fig. 1). The S1PL-
encoding genes of B. thailandensis and B. pseudomallei, and the corresponding proteins, 
show 84-92 % identity both within and between species. Furthermore, the Burkholderia 
proteins show approximately 37-39 % amino acid identity to the well-characterized human 
and yeast S1PL orthologues. Notably, all amino acids reported to be essential for the activity 
of the yeast S1PL orthologue (Dpl1) (Mukhopadhyay et al., 2008) are conserved in the 
Burkholderia S1PLs (Fig. S1). The Burkholderia proteins show only 32 % amino acid 
identity to the S1PL orthologue of L. pneumophila (LegS2), and the S1PL phylogenetic tree 
depicted in Fig. S2 emphasizes the diversity amongst S1PLs of prokaryotic and eukaryotic 
origin. Whilst LegS2 of L. pneumophila branches with eukaryotic S1PLs, consistent with its 
proposed protozoan origin (Degtyar et al., 2009), the S1PLs of B. pseudomallei and B. 
thailandensis branch with those of Symbiobacterium, Myxococcus and Stigmatella (with 
which they exhibit approximately 45 % amino acid identity). 
The two S1PL-encoding genes are conserved across all available B. pseudomallei and B. 
thailandensis genomes (Winsor et al., 2008), but are absent from the closely-related 
Burkholderia mallei. Within annotated B. pseudomallei and B. thailandensis genomes, there 
is inconsistent annotation of the S1PLs with regards the predicted position of the N-terminus 
(Fig. S3). S1PLs are pyridoxal 5’-phosphate (PLP)-dependent enzymes, and our initial 
studies of recombinant Burkholderia S1PLs revealed that the proteins only bound the PLP 
co-factor when cloned from the conserved MDLEEG sequence depicted in Fig. S3 (data not 
shown). Consequently, we adopted that conserved sequence as the N-terminus for all the 
studies described herein. Using that N-terminus, each S1PL-encoding gene of Burkholderia is 
predicted to encode a protein of approximately 52 kDa. However, the recombinant 
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Burkholderia S1PLs purify as homodimers when expressed in E. coli (data not shown), and 
native PAGE analysis of B. thailandensis expressing His-tagged BTH_II0309 or 
BTH_II0311 reveals the presence of oligomeric complexes (Fig. S4). This is consistent with 
the oligomeric nature of the yeast S1PL orthologue (Dpl1), which occurs as a dimer or 
multiple of dimers (Mukhopadhyay et al., 2008). 
The S1PL activity of the recombinant Burkholderia proteins was confirmed by measuring the 
formation of (2E)-hexadecenal from S1P by electrospray mass spectrometry (ESI-MS), based 
on a method from Berdyshev et al. (2011). The S1PL activity of the Burkholderia 
orthologues (exemplified by recombinant BTH_II0309) is demonstrated in Fig. 2, where 
BTH_II0309 catalysed the degradation of S1P with the resulting formation of hexadecenal. In 
addition, full biochemical characterization of the recombinant B. pseudomallei S1PLs was 
performed, confirming that both BPSS2021 and BPSS2025 are active and display similar KM 
values. These biochemical studies, together with the determination of the crystal structure of 
PLP-bound BPSS2021, will be described elsewhere (McLean et al., Unpublished data). 
Having confirmed the lyase activity of the Burkholderia S1PLs, we sought to determine 
whether they were functionally equivalent to their well-characterized yeast orthologues. The 
S1PL-deficient mutant of Saccharomyces cerevisiae (Δdpl1) is hypersensitive to D-erythro-
sphingosine (Saba et al., 1997), so we assessed whether the Burkholderia orthologues could 
restore D-erythro-sphingosine resistance to a Δdpl1 mutant. As shown in Fig. 3, resistance 
was partially restored by BTH_II0309 or BTH_II0311 individually, and fully restored by co-
expression of both. In addition to confirming that the bacterial S1PLs are functionally 
equivalent to eukaryotic orthologues, these observations also suggest that optimal S1PL 
enzymatic activity requires both Burkholderia proteins. Analogous to the phenotype of the 
Δdpl1 S. cerevisiae mutant, S1PL-deficient B. thailandensis mutants (described below) also 
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displayed hypersensitivity to D-erythro-sphingosine, a phenotype that was fully restored by 
complementation (Fig. S5). 
 
Secretion of B. thailandensis S1PLs is pH-dependent, and is observed during intracellular 
infection 
 
Any role for the Burkholderia S1PLs in virulence and/or immune evasion would be 
dependent on their secretion. B. thailandensis strains constitutively expressing FLAG-tagged 
BTH_II0309 or BTH_II0311 were constructed, enabling detection of FLAG-tagged proteins 
in cell pellets and culture supernatants by anti-FLAG immunoblotting. When cultured in LB 
adjusted to pH 4.5 or pH 7, the FLAG-tagged S1PLs were detected in whole-cell lysates 
regardless of the pH (Fig. 4A). In contrast, the S1PLs were only detected in the culture 
supernatants when cultured at pH 4.5. To exclude the possibility of S1PL secretion being an 
artefact arising from their constitutive overexpression whilst under acid-related stress, we 
confirmed that a non-secreted protein (GFP) when expressed in B. thailandensis under the 
same conditions was not detectable in culture supernatant by Western blot analysis (Fig. S6). 
Together, these results support the pH-dependent secretion of the Burkholderia S1PLs. 
A critical virulence factor of B. pseudomallei is the Bsa Type III secretion system that 
facilitates escape from endocytic vacuoles and intracellular survival (Stevens et al., 2002). In 
B. thailandensis, the activity of the orthologous system is stimulated by acidic pH 
(Jitprasutwit et al., 2010). To assess whether pH-dependent secretion of the B. thailandensis 
S1PLs is facilitated by the Bsa system, we inactivated bsaZ (BTH_II0839), a structural 
component of the Bsa secretion apparatus (Stevens et al., 2002). We did not detect secretion 
of the known T3SS effector BopE when the resulting Bsa-deficient mutant was cultured at 
acidic pH, confirming that the Bsa system was functionally inactive (Fig. S7A). In contrast, 
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we still observed pH-dependent secretion of the B. thailandensis S1PLs (Fig. S7B), 
indicating that their secretion is independent of the Bsa system. 
In an attempt to define the intracellular localisation of secreted Burkholderia S1PLs, we 
infected macrophages with the FLAG-tagged S1PL-expressing strains described above and 
assessed the localisation of the FLAG-tagged proteins 2 hours post infection (hpi). Although 
the strains constitutively express the S1PLs, different patterns of anti-FLAG reactivity were 
evident (Fig 4B), consistent with their secretion being influenced by environmental stimuli. 
In some infected macrophages, the FLAG-tagged S1PLs were entirely restricted to the 
bacterial cells themselves, indicative of non-secretion. In contrast, other infected 
macrophages exhibited diffuse anti-FLAG reactivity indicative of S1PL secretion. Attempts 
to define the localisation of secreted S1PLs within infected macrophages were inconclusive, 
as the proteins showed only limited colocalisation with each of the cellular compartments 
studied (ER, mitochondria, and cytoplasm; Fig. S8). 
 
Burkholderia-encoded S1PLs are required for intracellular survival 
 
To assess the role of the Burkholderia-encoded S1PLs in virulence, we created S1PL-
deficient mutants of both B. thailandensis E264 and B. pseudomallei K96243. The majority 
of our studies used B. thailandensis as our model organism. Owing to the genetic 
intractability of B. thailandensis, it was not possible to construct double mutants lacking both 
BTH_II0309 and BTH_II0311, thus single mutants were constructed by insertional 
inactivation. Selected experiments were also performed with B. pseudomallei in order to 
verify the B. thailandensis-based observations. In addition, as B. pseudomallei is more 
genetically-tractable, this enabled generation of a double mutant through the deletion and/or 
inactivation of both BPSS2021 and BPSS2025. B. thailandensis and B. pseudomallei mutants 
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were validated by PCR analysis, with the B. pseudomallei mutants further validated by whole 
genome sequencing. 
Given the importance of intracellular survival to B. pseudomallei pathogenesis and the 
documented role of S1P in macrophage activity and phagosome maturation, we focused on 
defining the contribution of the Burkholderia S1PLs to intracellular survival and replication. 
Murine macrophages were infected with wildtype or S1PL-deficient B. thailandensis or B. 
pseudomallei strains and intracellular replication was assessed over 6 hours. Both wildtype B. 
thailandensis and wildtype B. pseudomallei exhibited significant intracellular replication over 
this period (Fig. 5A & 5B respectively). In contrast, the corresponding S1PL-deficient 
mutants showed no apparent replication, with the number of viable bacteria significantly 
reduced relative to the respective wildtype strains by 6 hpi (Fig. 5A & 5B). Complementation 
of the single BPSS2025 mutant partially restored intracellular survival (Fig. S9). Notably, the 
single and double mutants of B. pseudomallei displayed a comparable phenotype (Fig. 5B).  
To gain insight into the mechanisms responsible for the impaired intracellular replication of 
the S1PL-deficient mutants, we assessed the localisation of RFP-expressing B. thailandensis 
strains (wildtype and S1PL-deficient mutants) with the lysosomal marker LAMP-1 at the 
same timepoints. LAMP-1, which is required for fusion of lysosomes with phagosomes 
(Huynh et al., 2007), is recruited during the late stage of phagosome maturation. 
Colocalisation of bacteria with LAMP-1 therefore indicates bacteria that have failed to escape 
from the maturing phagosome. The impaired intracellular replication of the S1PL-deficient 
mutants was associated with their increased localisation with LAMP-1, as demonstrated by 
representative micrographs (Fig. 5C) and quantitative analysis of LAMP-1 colocalisation 
(Fig. 5D). Collectively, these results indicate that the Burkholderia S1PLs play a role in 
intracellular replication and promote the avoidance of the maturing phagosome. 
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Burkholderia S1PLs are required for virulence in Galleria and murine models of infection. 
 
Initially, the role of the S1PLs in virulence was assessed using the B. thailandensis strains in 
the Galleria mellonella model of infection. Due to the high degree of functional homology 
between the innate immune system of insects and mammals, numerous studies have 
successfully applied the Galleria infection model to assess bacterial virulence. With 
particular relevance to the studies described herein, the Galleria model has been validated for 
several Burkholderia species, including B. thailandensis (Wand et al., 2011).  
Larvae were challenged with approximately 25 CFU of the relevant B. thailandensis strains 
and larval survival assessed at 40 hpi. For each independent experiment, multiple 
inoculations were performed for each strain and exact CFU counts determined for each 
inoculum to ensure comparisons between strains were robust. As shown in Fig. 6A, 
inactivation of the S1PL-encoding genes in B. thailandensis was associated with significant 
virulence attenuation, with infected larvae showing increased survival relative to larvae 
inoculated with wildtype B. thailandensis. Virulence of the individual mutants was fully 
restored by complementation (Fig. 6B & 6C). When studying the complemented strains 
alongside the mutants, the BTH_II0309 and BTH_II0311 strains were studied independently 
from each other, so as to accommodate the multiple inoculations per strain. This explains the 
differing larval survival rates observed when comparing Fig. 6A-C, as survival is influenced 
by minor variations in inoculum (± 20 CFU) and batch-to-batch variation in Galleria. When 
studied alongside each other, there is no difference in the virulence of the two mutants, with 
both showing comparable attenuation (Fig. 6A). 
On the basis of the virulence attenuation observed in the Galleria model coupled with the 
failure of S1PL-deficient Burkholderia to replicate within murine macrophages, we assessed 
the virulence of the B. pseudomallei ΔBPSS2025 mutant in a murine infection model. Balb/c 
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mice were inoculated with B. pseudomallei via the intraperitoneal route and survival was 
monitored for five weeks. Mice infected with 3.8 x 104 CFU of wildtype B. pseudomallei all 
died within 17 days (median survival 12 days). In contrast, mice challenged with a slightly 
higher inoculum of ΔBPSS2025 (5.6 x 104 CFU) exhibited 80 % survival at the end of the 5 
week study period (Fig. 7; p = 0.0064). Determined LD50 values for B. pseudomallei wildtype 
and ΔBPSS2025 were < 3790 CFU and 170,500 CFU respectively, confirming the significant 
attenuation of the S1PL-deficient mutant. Complementation of the ΔBPSS2025 mutant failed 
to restore virulence in the murine model (determined LD50 = 178,668 CFU). However, 
plating of tissue homogenates from mice chronically-infected with the complemented strain 
revealed that all recovered bacteria were fully sensitive to tetracycline, suggesting that the 
lack of complementation is a consequence of plasmid instability during infection. 
 
Exogenous S1P receptor agonists enhance the bactericidal activity of Burkholderia-infected 
macrophages 
 
Given the clear role of the B. thailandensis and B. pseudomallei S1PLs in promoting 
virulence and intracellular survival, we sought to explore whether treatment of infected 
macrophages with S1P or an appropriate S1PR agonist could circumvent the activity of the 
secreted bacterial S1PLs, promoting the activity of the S1P pathway and thus aiding bacterial 
killing. The expression patterns of the five S1PRs that mediate the extracellular activities of 
S1P vary across different cells & tissues. Murine macrophages reportedly express just S1PR1 
and S1PR2 (Hughes et al., 2008), and whilst there are no reported mono-selective S1PR2 
agonists, several S1PR1-selective agonists have been described. Therefore, in the present 
study, we chose to assess the impact of S1P pathway modulation on the bactericidal activity 
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of infected macrophages using both S1P (the natural agonist of both S1PR1 and S1PR2) and 
the S1PR1-selective agonist, CYM-5442 (Gonzalez-Cabrera et al., 2008). 
Murine macrophages were infected with wildtype B. thailandensis or B. pseudomallei (MOI 
10) for two hours prior to treatment with S1P or CYM-5442 (neither of which possess direct 
antimicrobial activity; data not shown), and the intracellular survival of bacteria was assessed 
2 and 6 hours post-treatment. Following 6 hours treatment, S1P and CYM-5442 both elicited 
a comparable reduction in bacterial survival within B. thailandensis- and B. pseudomallei-
infected macrophages (Fig. 8A & 8B respectively). No significant reduction was observed 2 
hours post treatment (data not shown). This reduction in viable intracellular bacteria 
following S1P/CYM-5442 treatment was associated with an increase in bacterial 
colocalisation with LAMP-1 (Fig. 8C & 8D), consistent with the attenuated intracellular 
phenotype of the S1PL-deficient mutants. Based on these results, we conclude that S1P 
pathway modulation is an attractive therapeutic strategy for the treatment of intracellular 
bacterial infections, with beneficial bactericidal activity attributable to the specific activation 
of the S1PR1 pathway.  
 
Discussion 
Our studies described herein highlight a previously-unrecognised strategy employed by B. 
pseudomallei to subvert host cell function and promote intracellular survival and virulence. 
Together with previous reports focusing on M. tuberculosis (Malik et al., 2003; Thompson et 
al., 2005), S. flexneri (Kim et al., 2014) and L. pneumophila (Abu Khweek et al., 2016; 
Degtyar et al., 2009; Rolando et al., 2016), our studies further highlight the host S1P axis as 
an emerging field in bacterial pathogenesis and host-microbe interactions, with bacteria 
employing different strategies to subvert the S1P pathway. In the context of macrophage 
activity, S1P can influence endosome-endosome and phagosome-lysosome fusion via distinct 
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mechanisms, including mobilisation of intracellular calcium (Blom et al., 2005) and the 
stimulation of actin assembly (Anes et al., 2003; Kuehnel et al., 2009). Data presented herein 
highlight the role of the Burkholderia-encoded S1PLs in virulence and intracellular survival, 
the latter attributable to their role in promoting the evasion of the maturing phagosome. It 
remains to be established whether this S1PL-mediated phagosome avoidance arises through 
an actual delay to S1P-mediated phagosome maturation via disruption of host cell S1P levels, 
or through promoting bacterial escape from the phagocytic vacuole via an undetermined 
mechanism. Regardless of the mechanism(s) involved, we propose the secreted S1PLs act in 
concert with documented Burkholderia intracellular survival strategies, including the Bsa 
Type III secretion system that is known to facilitate escape from endocytic vacuoles (Stevens 
et al., 2002). Whilst our data suggest that the Burkholderia S1PLs are not effectors of the Bsa 
system, S1PL secretion is similarly regulated in a pH-dependent manner and can be observed 
during macrophage infection.  
Strikingly, the Burkholderia-encoded S1PLs described herein appear phylogenetically 
distinct from the Legionella orthologue, which to date is the only other prokaryotic S1PL to 
be implicated in pathogenesis (Abu Khweek et al., 2016; Rolando et al., 2016). Furthermore, 
whilst the S1PLs of B. thailandensis and B. pseudomallei are required for intracellular 
replication, the S1PL of Legionella contributes to the restriction of intracellular growth, with 
S1PL-deficient L. pneumophila mutants showing enhanced intracellular replication (Abu 
Khweek et al., 2016; Rolando et al., 2016). Although the molecular mechanisms underlying 
these contrasting intracellular phenotypes remain to be elucidated, they may reflect the 
differing intracellular lifestyles of these organisms, as whilst B. pseudomallei and B. 
thailandensis both escape from endosomes and replicate freely within the cytosol, L. 
pneumophila intracellular replication occurs within the confines of the Legionella-containing 
vacuole (LCV). Further comparative studies are required to ascertain how these 
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Burkholderia- and Legionella-encoded S1PLs elicit their differing effects, taking into account 
the timing of their secretion, their targeting within infected host cells and their interplay with 
other bacterial effectors. As highlighted previously, S1P acts as both an intracellular second 
messenger and as an autocrine/paracrine ligand for five distinct S1P receptors (S1PRs). 
Consequently, when considering the precise mechanisms of the secreted S1PLs of Legionella 
and Burkholderia species during intracellular infection, there exists both S1PR-dependent 
and S1PR-independent scenarios to explain their biological activity. Depletion of the 
intracellular S1P pool by the bacterial lyases may impair both the intracellular activity of S1P 
and the autocrine signalling via S1PRs (where S1P synthesized within the cell is exported to 
activate its own receptors). Notably, and with particular relevance to the present study, both 
intracellular and extracellular signalling pathways have been shown to converge on calcium 
mobilisation from the ER (Li et al., 2015; Ghosh et al., 1994; Ghosh et al., 1990), a process 
that underpins phagosome maturation. This convergence of S1PR-dependent and independent 
signalling pathways on calcium mobilisation likely explains the concordance of phenotypes 
observed in the present study, where macrophages infected with S1PL-deficient mutants 
showed the same phenotype as macrophages treated with exogenous S1P (namely, enhanced 
bacterial colocalisation with LAMP-1 and reduced intracellular survival; Fig. 5 & 8).  
Previous functional and structural studies of S1PL orthologues from other species (notably of 
yeast and the bacterial species, Symbiobacterium thermophilum; Bourquin et al., 2010) 
provide us with valuable clues as to the structure and catalytic activity of the Burkholderia 
proteins. However, the Burkholderia S1PLs merit further study in their own right as they 
display several unusual features when considered in the context of the PLP-dependent 
enzyme superfamily (reviewed by Eliot and Kirsch, 2004), namely the presence of two copies 
of highly homologous genes, their extracellular location and their potential higher order 
structure. To our knowledge, there are no other instances of organisms possessing two 
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distinct S1PL-encoding genes, as is evident in B. thailandensis and B. pseudomallei. Data 
from previously published transcriptomic studies of B. pseudomallei have revealed that both 
S1PL-encoding genes are expressed under wide-ranging culture conditions (Ooi et al., 2013) 
and during intracellular infection of macrophages (Chieng et al., 2012). Whilst we have 
observed that each of the recombinant homodimeric Burkholderia S1PLs possess enzymatic 
activity individually, the higher degree of sphingosine resistance conferred by co-expression 
of BTH_II0309 and BTH_II0311 in S. cerevisiae Δdpl1 (Fig. 3) suggests that a hetero-
oligomer may be required for optimal enzymatic activity. In such a scenario, inactivation or 
deletion of one of the S1PL-encoding genes would be sufficient to disrupt enzymatic activity, 
potentially explaining why each of the individual B. thailandensis mutants characterized 
herein display a comparable phenotype (Fig. 5 & 6), and why the single and double mutants 
in B. pseudomallei are also phenotypically indistinguishable (Fig. 5). Whilst we have 
observed oligomeric Burkholderia S1PL (Fig. S4), to date we have been unable to determine 
whether the observed oligomers are hetero- or homo-oligomeric, or a combination of both.  
The targeting of the Burkholderia S1PLs following their secretion within the infected host 
cell is equally enigmatic. Eukaryotic S1PL is predominantly localised to the endoplasmic 
reticulum (ER) membrane where the S1P substrate is abundant (Ikeda et al., 2004), whilst the 
S1PL orthologue of L. pneumophila (LegS2) has been reported to localise to both the 
mitochondria and the ER (Degtyar et al., 2009; Rolando et al., 2016), with the suggestion that 
it may localise to the contact sites between the two organelles (Rolando et al., 2016). In our 
studies, the Burkholderia S1PLs did not show conclusive localisation to any of the cellular 
compartments studied (Fig. S8), nor does their sequence provide any clues as to their 
intracellular targeting. It should be stressed that the biosynthesis of S1P is very dynamic – 
both temporally and spatially. For example, whilst sphingosine kinase 1 (SphK1) is primarily 
a cytosolic protein in unstimulated mammalian cells, it rapidly translocates to the plasma 
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membrane, intracellular organelles (including the phagosome; Thompson et al., 2005) and 
cytoskeleton in response to diverse cellular stimuli (for review, see Siow and Wattenberg, 
2011). Consequently, future high resolution mapping of the temporal and spatial secretion of 
Burkholderia S1PLs during infection of host cells, in conjunction with sphingolipidomic 
analyses, will be fundamental to providing mechanistic insight into their precise role in 
pathogenesis and host S1P pathway disruption.  
S1P has been widely implicated in human health and disease, and the therapeutic 
opportunities around S1P pathway modulation are numerous. Agonists, antagonists and 
inhibitors of the S1PRs and/or enzymes of the S1P biosynthetic/catabolic pathway are at 
various stages of clinical development for the treatment of diverse conditions including 
cancer, neurodegenerative disorders and inflammatory diseases (for review, see Proia and 
Hla, 2015). Clinical experience with the S1PR agonist FTY720 (GilenyaTM), approved as the 
first oral treatment for multiple sclerosis (Brinkmann et al., 2010), proves that it is possible to 
specifically target the S1P pathway without serious adverse effects. The pivotal role played 
by S1P in immune function has also prompted studies of S1PR agonists as novel therapeutics 
for the treatment of fungal, viral and bacterial infections. In our own study, we demonstrated 
that exogenous S1PR agonists (S1P and CYM-5442) enhance the bactericidal activity of 
Burkholderia-infected macrophages (Fig. 8), an effect that has also been observed following 
S1P-treatment of Mycobacterium-infected macrophages (Garg et al., 2004). Thus, S1PR-
dependent processes play a pivotal role in regulating macrophage activity and their ability to 
control intracellular pathogens. S1PR agonists have also shown efficacy in infection models 
via other distinct mechanisms, for example through the reduction of infection-associated 
immunopathology in models of influenza (Teijaro et al., 2014; Walsh et al., 2011), 
lipopolysaccharide-mediated acute lung injury (Peng et al., 2004), Bordetella pertussis 
infection (Skerry et al., 2015) and M. tuberculosis infection (Garg et al., 2004). Furthermore, 
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through its action on immune cell trafficking, the S1PR agonist FTY720 reduces the 
dissemination of Francisella tularensis from the airways in a murine infection model (Bar-
Haim et al., 2008). Collectively, these studies demonstrate that by harnessing the 
immunomodulatory activity of the S1P pathway, S1PR agonists have considerable potential 
as novel anti-infectives.   
In summary, we describe the characterization of secreted S1PLs of B. pseudomallei and B. 
thailandensis that are required for intracellular replication and virulence, providing novel 
insight into the mechanisms by which these facultative intracellular organisms can evade host 
cell function. Our studies further highlight the S1P axis as a pivotal regulator of host-
pathogen interactions and as a potential therapeutic target for the treatment of infectious 
diseases. Future studies should capitalize on the availability of existing S1P-targeted 
compounds and the associated clinical knowledge, with the aim of repurposing the latest 
generation of selective S1PR agonists as novel immunomodulatory-based anti-infectives. 
 
Experimental Procedures 
Bacterial strains, cells lines and culture conditions 
Bacterial strains and plasmids are listed in Supplementary Information (Table S1). Bacteria 
were routinely cultured with aeration in Luria broth (LB) at 37 °C. As required, antibiotics 
were used at the following concentrations: kanamycin 25 μg ml-1; gentamicin 50 μg ml-1; 
trimethoprim 100 μg ml-1; tetracycline 100 μg ml-1. J774A.1 murine macrophages were 
routinely cultured in Dulbecco’s modified Eagle’s medium (DMEM; GE Healthcare) 
supplemented with 10 % foetal bovine serum (Gibco) at 37 °C in 5 % CO2. 
 
Recombinant Expression of Burkholderia S1PLs.  
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S1PL-encoding genes from B. thailandensis E264 and B. pseudomallei K96243 were PCR-
amplified and cloned into pET-28a (Novagen, Madison, WI). The protein was expressed with 
a twenty residue N-terminal tag containing a six-histidine motif to allow isolation by 
immobilised metal affinity chromatography. Expression plasmids were transformed into the 
E. coli strain BL21 (DE3) for protein expression. Typically, cells were grown at 37 °C to an 
optical density (600 nm) of 0.6, prior to induction of protein expression with 0.1 mM 
isopropyl-β-D-thiogalactoside (IPTG) for 4 hours at 30 °C. Cells were harvested by 
centrifugation, lysed by sonication, and purified using HisTrap affinity and size exclusion 
chromatography (Superdex S200) on an AKTA FPLC system (GE Healthcare). Eluted 
protein was flash-frozen and stored at -80 °C in 20 mM HEPES/150 mM NaCl/10 % glycerol 
(pH 7.5). Protein concentrations were measured using the BCA assay (Pierce, Rockford, IL) 
and all proteins were determined to be >90 % pure by Protein-PAGE. 
 
Assay of S1PL activity by ESI-MS 
The lyase activity of recombinant Burkholderia S1PLs was confirmed by measuring the 
formation of (2E)-hexadecenal (HEX) as a semicarbazone derivative by electrospray 
ionisation mass spectrometry (ESI-MS) based on a method from (Berdyshev et al., 2011). 
Briefly an enzyme stock solution was prepared by dialysing 10 µM S1PL in 20 mM HEPES 
(pH 7.5), 400 mM NaCl, and 100 µM PLP. A 2.6 mM S1P stock was prepared in 0.1 % 
Triton X-100 with additional sonication. Using these stocks an enzyme assay was prepared to 
a final volume of 500 µl containing 6 µM S1PL and 0.26 mM S1P substrate in a reaction 
buffer containing 20 mM HEPES, 400 mM NaCl and 0.1 mM PLP. Control assays lacking 
S1PL and S1P substrate were prepared accordingly and all samples were incubated for 20 
minutes at 37 °C. Methanol was added to stop the reaction and the HEX semicarbazone 
(HEX-SC) derivative was generated by heating the reaction at 40 °C for 2 h with 0.2 ml of 5 
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mM semicarbazide hydrochloride in methanol containing 5 % formic acid. A HEX standard 
(prepared as described previously; (Liu et al., 2010)) was treated in the same way. The 
resultant semicarbazone was analysed by direct infusion MS on a micro-TOF2 (Bruker) in 
ESI-positive mode. Ion spray voltage was held at 4.5 kV at a temperature of 200 °C with a 
Hexapole RF of 70 V peak-to-peak and Skimmer 2 potential of 20 V. 
 
Sphingosine antimicrobial assay 
The antimicrobial activity of D-erythro-sphingosine C-18 (Cayman chemical; MI, USA) was 
assessed as described previously (Possemiers et al., 2005), with minor modifications. Briefly, 
standardised bacterial suspensions (106 CFU ml-1) derived from overnight cultures were 
incubated for 2 hours at 37 ºC with agitation in a saline solution supplemented with D-
erythro-sphingosine (25 μM, dissolved in ethanol). After incubation, serial dilutions were 
plated onto LB agar plates for enumeration of CFU. Survival was determined by comparison 
to ethanol only controls. 
 
Complementation of Saccharomyces cerevisiae Δdpl1 
BTH_II0309 and BTH_II0311 genes were codon-optimised for S. cerevisiae expression by 
gene synthesis (Invitrogen) and cloned into the Gateway pDONR221 vector (Life 
Technologies) to create pENTR::BTH_II0309 and pENTR::BTH_II0311 respectively. The 
BTH_II0309 and BTH_II0311 sequences were subsequently cloned from the pENTR vectors 
into pAG413GPD-ccdB and pAG415GPD-ccdB yeast destination vectors respectively using 
LR Clonase recombination (Invitrogen), generating the expression plasmids 
pDEST413::BTH_II0309 and pDEST415::BTH_II0311. A similar process was used to 
construct pDEST413::dpl1, expressing the S. cerevisiae S1PL orthologue. The S. cerevisiae 
BY4741 (parental strain) and YDR294C (Δdpl1) strains were transformed with the 
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appropriate plasmids as described previously (Agatep et al., 1998). Transformants were 
selected on the basis of histidine (pAG413GPD-ccdB) and/or leucine (pAG415GPD-ccdB) 
prototrophy and were verified by PCR. 
 
Saccharomyces cerevisiae sphingosine resistance assay 
S. cerevisiae strains were grown in selective minimal liquid culture medium at 30 °C 
overnight with agitation. Serial dilutions of standardized culture were spotted onto YNB agar 
with or without supplementation with 10 µM D-erythro-sphingosine C-18. Plates were 
incubated at 30 °C for 48-72 h prior to visual assessment of growth. 
 
Detection of FLAG-tagged S1PLs in bacterial lysates and culture supernatant 
B. thailandensis constitutively expressing either FLAG-tagged BTH_II0309 or FLAG-tagged 
BTH_II311 were grown to mid-log phase in LB broth adjusted to either pH 7 or pH 4.5 and 
cells harvested by centrifugation. Bacterial cells were lysed in NuPAGE LDS Sample Buffer 
(Novex), whilst culture supernatants were filtered and proteins precipitated with 10 % (v/v) 
trichloroacetic acid. Proteins recovered from the whole cell lysates and culture supernatants 
were separated on 4-12 % NuPAGE SDS-PAGE (Novex) gel and transferred to nitrocellulose 
membrane. BTH_II0309-FLAG and BTH_II0311-FLAG were detected by Western blot 
using 1:1000 mouse anti-FLAG (Invitrogen) and 1:15000 goat anti-mouse LI-COR® IRDye 
800cw. The protein bands were visualised with the LI-COR Odyssey scanner and software. 
 
Construction of mutants and complemented strains 
S1PL-deficient mutants of B. thailandensis E264 and B. pseudomallei K96243 were 
generated via either insertional inactivation using pGPΩTp (Flannagan et al., 2007) or 
unmarked gene deletions using pDM4 and sacB-based counterselection (Logue et al., 2009). 
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Complementation of the mutants was achieved using the previously described pDA17 vector 
(Flannagan et al., 2008), that drives constitutive expression from a dhfr promoter. All 
plasmids (for mutagenesis and complementation) were mobilised into B. thailandensis or B. 
pseudomallei by triparental mating using the helper plasmid, pRK2013 (Figurski and 
Helinski, 1979). All mutants and complemented strains were confirmed by appropriate PCR 
validation, with the B. pseudomallei deletion mutant (ΔBPSS2025) further validated by whole 
genome sequencing. 
 
Phagocytic uptake and intracellular survival assays 
Bacterial uptake and subsequent intracellular survival in macrophages was assessed using a 
modified kanamycin protection assay as described previously (Wand et al., 2011). In 
summary, J774A.1 macrophages were incubated with relevant B. thailandensis or B. 
pseudomallei strains (MOI 10) for 2 h to allow bacterial internalization, after which the 
medium was replaced with fresh L15 supplemented with kanamycin (1000 µg ml-1) to kill 
extracellular bacteria. Viable intracellular bacteria were enumerated at 2 and 6 hpi by plating 
serial dilutions of macrophage lysates.  
 
Immunofluorescence microscopy for bacteria/LAMP-1 colocalisation studies 
J774A.1 macrophages seeded onto 12 mm diameter glass coverslips were infected (MOI 10) 
with wildtype B. thailandensis and the BTH_II0309 and BTH_II0311 mutants transformed 
with the reporter plasmid pBHR4-groS-RFP (Wand et al., 2011). After treatment with 
kanamycin (1000 µg ml-1) to kill extracellular bacteria, monolayers were washed twice with 
PBS and fixed with paraformaldehyde (4 % w/v in PBS; 15 min, room temperature). Cells 
were permeabilized with saponin (0.5 % v/v in PBS; 1 h) and non-specific binding sites 
blocked with 1 % (v/v) bovine serum albumin (BSA) in PBS. LAMP-1 was stained with 
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1:100 rabbit polyclonal antibody (Abcam) and the bound antibody was detected with 1:400 
goat anti-rabbit IgG-Alexa 488 (Molecular probes). The stained cells were washed three 
times with PBS, mounted onto slides using Vectashield (Vector Laboratories) and visualized 
using a Zeiss Axioplan epifluorescent microscope equipped with an oil immersion lens (Zeiss 
100× A-plan). Image analysis and processing was performed using Fiji (Schindelin et al., 
2012). A minimum of 100 bacteria were counted per strain/condition for each experiment. 
Colocalisation between bacteria and LAMP-1 was considered when bacteria were surrounded 
by a ring-like LAMP-1-enriched structure, indicating that the membrane of the Burkholderia-
containing phagosome is positive for LAMP-1. 
 
S1P and S1PR1 agonist treatment of macrophages 
S1P (Cayman Chemical; MI, USA) and the water-soluble S1PR1 selective agonist CYM-
5442 (Tocris Biosciences; Bristol, UK) were added to infected J774A.1 monolayers after a 2 
h infection period with wildtype B. thailandensis E264 or B. pseudomallei K96243 (MOI 10). 
S1P was added at a final concentration of 5 µM, a concentration previously shown to elicit a 
strong anti-mycobacterial response in infected macrophages (Garg et al., 2004). CYM-5442 
was added at a final concentration of 0.5 µM, a concentration known to activate the S1PR1-
dependent pathways in vitro (Gonzalez-Cabrera et al., 2008). Colocalisation of bacteria with 
LAMP-1 and/or intracellular survival within treated and untreated macrophages was then 
assessed as described above. 
 
Fluorescent staining of FLAG-tagged S1PLs in infected macrophages  
J774A.1 cells were infected with B. thailandensis expressing either FLAG-tagged 
BTH_II0309 or FLAG-tagged BTH_II311 (MOI 50). Following killing of extracellular 
bacteria (1000 µg ml-1 kanamycin, 2 hours), infected cells were fixed with paraformaldehyde 
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and permeabilized with saponin as described above. Non-specific binding sites were blocked 
with Image-iT® FX signal enhancer (Life technologies) for 30 min at room temperature, 
prior to overnight incubation (4 ºC) with mouse anti-FLAG (Invitrogen) and rabbit anti-
Calnexin (Abcam) primary antibodies (each diluted 1:250 in 10 % normal goat serum / 0.1 % 
PBS-Tween 20). Bound primary antibodies were subsequently detected with 1:400 dilutions 
of goat anti-mouse Alexa 488 and goat anti-rabbit Alexa 594 (Molecular probes). Following 
washing, the stained cells were mounted and visualized as described above. 
 
Galleria mellonella infection model 
Virulence of relevant B. thailandensis strains was assessed using the G. mellonella infection 
model as described previously (Wand et al., 2011), with an inoculum of approximately 25 
CFU per larvae. For each independent experiment, inoculations were performed with 
multiple inoculum dilutions for each strain and exact CFU counts for each inoculum were 
determined to ensure comparisons between strains were robust (as minor variation from the 
intended 25 CFU inoculum impacted on larval survival). Larval survival was assessed 40 
hours post-infection (hpi).  
 
BALB/c murine infection model 
Investigations involving animals were carried out according to the requirements of the UK 
Animal (Scientific Procedures) Act 1986 under project licence PPL 30/3026. This project 
licence was approved following an ethical review by Dstl’s Animal Welfare and Ethical 
Review Body. Studies were performed using female BALB/cAnNCrl mice (BALB/c; Charles 
River UK) implanted with a sub-cutaneous Pico transponder (Uno BV, Netherlands) to allow 
individual mice to be tracked through the study. On arrival into containment level 3 animal 
facilities, mice were randomly allocated into cages of five animals and acclimatised to their 
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new surroundings for five days before any procedures were performed. Animal husbandry 
practices and environmental conditions during study were as described previously (Scott et 
al., 2016). Challenges were performed with B. pseudomallei K96243 prepared as described 
previously (Scott et al., 2016) and delivered via the intraperitoneal route. Mice received one 
of three different inocula per strain (five mice per strain per inoculum), corresponding to 
approximately 3.8 x 103 –3.8 x 105 CFU B. pseudomallei K96243 and 5.6 x 104 – 5.6 x 106 
CFU B. pseudomallei ΔBPSS2025. Mice were checked at least twice daily following 
challenge and clinical signs for each mouse recorded for five weeks post-infection. Humane 
end-points were used throughout these studies to minimise suffering, with culls performed 
via cervical dislocation at the end-point. At the end of the study, animals were culled and 
organs removed for enumeration of bacterial burden (lungs, liver, spleen). These were 
mashed through 40 μm sieves into PBS, serially diluted and plated onto L-agar.   
 
Statistical analysis 
Kaplan–Meier survival curves were generated using GraphPad PRISM v6 and analysed using 
a log rank (Mantel-Cox) test within PRISM. The LD50 for each strain was determined using 
the method of Reed and Muench (Reed and Muench, 1938). For all other assays, statistical 
analyses were performed by one-way ANOVA with Tukey post hoc testing (for multiple 
comparisons) or Student’s t-test (for pairwise comparisons). In all cases, p < 0.05 was 
deemed statistically significant.  
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Fig. 1. S1PL-encoding genomic regions of B. pseudomallei K96243 and B. thailandensis 
E264. Each organism possesses two S1PL-encoding genes (highlighted in black) located 
within the same genomic region. A high degree of synteny exists between the S1PL-encoding 
regions of each species. For ease of comparison, the B. thailandensis genomic region is 
depicted in reverse orientation.  
35 
 
 
Fig. 2. Demonstration of lyase activity of recombinant Burkholderia S1PL by ESI-MS. 
The lyase activity of recombinant Burkholderia S1PLs (exemplified here by BTH_II0309) 
was confirmed by using ESI-MS to assess the formation of (2E)-hexadecenal (HEX) as a 
semicarbazone derivative (HEX-SC) from S1P. (A) HEX standard reaction showing an ion 
consistent with HEX-SC ([M+H]+, C17H34N3O, predicted m/z = 296.3). (B) No enzyme 
control, showing no HEX-SC formation and an ion consistent with the mass of the S1P 
substrate ([M+H]+, C18H39NO5P = 380.2). (C) Incubation of S1P with recombinant 
BTH_II0309 results in the degradation of S1P and formation of HEX-SC (evidenced by 
coexistence of ions with m/z = 296.3 and 380.2). 
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Fig. 3. The S1PLs of B. thailandensis functionally complement S1PL-deficient yeast. 
Burkholderia S1PLs codon-optimized for expression in yeast were synthesized and cloned 
into S1PL-deficient S. cerevisiae Δdpl1.  Serial dilutions of transformants were spotted onto 
YNB agar ± 10 µM D-erythro-sphingosine. The results are representative of three 
independent experiments following 48-72 h incubation, and confirm that the Burkholderia 
proteins functionally complement the yeast mutant.  
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Fig. 4. Secretion of B. thailandensis S1PLs is pH-dependent, and can be observed during 
intracellular infection. (A) Wildtype B. thailandensis and B. thailandensis constitutively 
expressing FLAG-tagged S1PL (BTH_II0309 or BTH_II0311) were cultured at pH 7 or pH 
4.5. Proteins from whole-cell lysates and culture supernatants were separated by SDS-PAGE, 
transferred to a nitrocellulose membrane and probed with anti-FLAG antibody. The S1PL 
proteins were only detected in culture supernatant from B. thailandensis cultured at pH 4.5. 
No anti-FLAG reactivity was observed for the wildtype B. thailandensis, thus excluding 
cross-reactivity with endogenous proteins. (B) J774A.1 cells were infected with B. 
thailandensis expressing BTH_II0309-FLAG or BTH_II0311-FLAG (MOI 50). The 
endoplasmic reticulum and S1PL-FLAG proteins were stained with anti-Calnexin and anti-
FLAG antibodies respectively (in conjunction with appropriate secondary antibodies; refer to 
Materials and Methods), and cell nuclei were stained with DAPI. Top panels show FLAG-
tagged S1PL detection restricted to bacterial cells, whilst bottom panels show staining 
indicative of S1PL secretion. Right insets represent magnified images of boxed areas. White 
arrows indicate intracellular bacteria, whilst the arrow head indicates secreted S1PL. No 
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FLAG reactivity was detected in macrophages infected with wildtype B. thailandensis (not 
shown). Scale bar represents 10 µm. 
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Fig. 5. S1PL-deficient Burkholderia exhibit impaired intracellular replication and 
increased colocalisation with LAMP-1-containing vesicles in macrophages. (A & B) 
J774A.1 macrophages were infected with relevant strains of B. thailandensis (A) or B. 
pseudomallei (B). Viable intracellular bacteria were quantified at 2 and 6 hpi by spotting 
serial dilutions of macrophage lysates. For each strain, bacterial survival was normalised to 
the CFU counts observed at 2 hpi and presented as relative bacteria survival (%) so as to 
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visualise intracellular replication between 2 and 6 hpi. For both B. thailandensis and B. 
pseudomallei, the S1PL-deficient mutants showed impaired intracellular replication relative 
to the respective wildtype. Notably, the two individual S1PL mutants of B. thailandensis 
exhibited a comparable phenotype (A), as did the single and double mutants of B. 
pseudomallei (B). (C & D) Assessment of the colocalisation of RFP-expressing B. 
thailandensis strains with the lysosomal marker LAMP-1 demonstrated that S1PL-deficient 
mutants exhibit increased LAMP-1 colocalisation. In representative micrographs (C), right 
insets represent magnified images of boxed areas and the yellow arrows indicate bacterial 
colocalisation with LAMP-1. Scale bar represents 10 µm. For quantitative analysis of 
bacterial colocalisation with LAMP-1 (D), positive or negative colocalisation was assessed 
for 100 intracellular bacteria per strain per independent experiment to achieve a percentage 
colocalisation. Data shown represent the mean ± SEM of three independent experiments. * 
p<0.01; ** p<0.001; *** p<0.0001. 
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Fig. 6. B. thailandensis S1PLs are required for virulence in a larval infection model. 
Virulence of relevant B. thailandensis strains was assessed using the Galleria mellonella 
infection model using an inoculum of approx. 25 CFU and assessing percentage larval 
survival at 40 hpi. (A) Relative to the wildtype, both the individual BTH_II0309 and 
BTH_II0311 mutants exhibit comparable attenuated virulence, with delayed larval killing. (B 
& C) Complementation fully restored virulence to the BTH_II0309 and BTH_II0311 mutants. 
When studying the complemented strains alongside the mutants, the BTH_II0309 and 
BTH_II0311 strains were studied independently from each other, so as to accommodate 
multiple inoculations per strain (refer to main text for details). This is reflected in the 
differing larval survival observed between panels B & C, which show analysis of 
BTH_II0309 and BTH_II0311 strains respectively. When studied alongside each other, there 
is no difference in the virulence of the two mutants (panel A). Results represent the mean ± 
SEM of three independent experiments (10 larvae per strain, per experiment). * p < 0.05, ** p 
< 0.005.   
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Fig. 7. B. pseudomallei S1PL contributes to virulence in a murine model of infection. 
Virulence of B. pseudomallei ΔBPSS2025 was assessed using an intraperitoneal infection 
model in BALB/c mice. Data show the survival (over a five week period) of mice inoculated 
with approximately 4 x 104 CFU of either wildtype or ΔBPSS2025 B. pseudomallei, 
demonstrating significant attenuation of the BPSS2025-deficient mutant (p = 0.0064).    
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Fig. 8. Treatment of Burkholderia-infected macrophages with S1P or an S1PR1 agonist 
enhances bacterial killing. (A & B) J774A.1 macrophages were infected with wildtype B. 
thailandensis (A) or B. pseudomallei (B) for 2 h, prior to treating with S1P or CYM-5442 
(alongside relevant carrier only controls). Viable intracellular bacteria were quantified after 6 
hours and percentage survival calculated relative to controls. For both species, S1P and 
CYM-5442 treatments resulted in comparable reductions in surviving intracellular bacteria. 
(C & D) Assessment of the colocalisation of RFP-expressing B. thailandensis strains with the 
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lysosomal marker LAMP-1 in infected macrophages with or without S1P treatment.  S1P-
treatment enhanced bacterial colocalisation with LAMP-1, as indicated in representative 
micrographs (C) and via quantitative analysis (relative to carrier only control; D). (C) Right 
insets represent magnified images of boxed areas, with the yellow arrows indicating bacterial 
colocalisation with LAMP-1. Scale bar represents 10 µm. (D) For quantitative analysis, 
positive or negative colocalisation was assessed for 100 intracellular bacteria per strain per 
independent experiment to achieve a percentage colocalisation. In panels A, B & D, data 
represent mean ± SEM of three independent experiments. * p < 0.01; ** p < 0.001. 
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Figure S1. Amino acid alignment of representative Burkholderia and eukaryotic S1PLs. Sequence 
alignment of BPSS2025, BPSS2021, BTH_II0309, BTH_II0311, human & yeast S1PL. Asterisks indicate 
amino acid residues that are important for the enzymatic activity of the yeast protein 
(Mukhopadhyay et al., 2008), all of which are conserved in the Burkholderia orthologues. Accession 
numbers: Human S1PL, CAA09590; Yeast S1PL, AHY75267. Alignment generated using Vector NTI 
Advance 11 (Invitrogen), with blue, green and yellow shading indicating similarities (“conserved”, 
“block of similar”, and “identical” respectively). 
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Figure S2. Phylogenetic tree of representative prokaryotic and eukaryotic S1PL orthologues. 
Representative protein sequences were aligned using the MUSCLE programme (Edgar, 2004), and 
the subsequent tree visualized using Phylodendron (http://iubio.bio.indiana.edu/treeapp/treeprint-
form.html). Glutamate decarboxylase from Francisella was used as an outgroup (glu_decarb). 
Legionella and Burkholderia S1PL orthologues are highlighted with red and blue arrows respectively. 
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Figure S3. Alignment of the N-terminal region of representative Burkholderia S1PLs. Alignment of 
the N-terminal region of selected Burkholderia orthologues drawn from the Burkholderia genome 
database (Winsor et al., 2008) reveal inconsistencies in the prediction of the N-terminus. Only when 
cloned from the conserved MDLEEG sequence did the Burkholderia S1PL orthologues exhibit the 
anticipated enzymatic activity. Sequences depicted: BPSS2021 & BPSS2025 (B. pseudomallei 
K96243), BTH_II0309 & BTH_II0311 (B. thailandensis E264), A2756 & A2761 (B. pseudomallei 1106a) 
and A2912 & A2918 (B. pseudomallei 668). Alignment generated using Vector NTI Advance 11 
(Invitrogen), with blue, green and yellow shading indicating similarities (“conserved”, “block of 
similar”, and “identical” respectively). 
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Figure S4. Western blot analysis of native His-tagged BTH_II0309 and BTH_II0311 indicates 
oligomeric complexes. Using B. thailandensis E264 as a parental strain, sequence encoding a 6x His-
tag was integrated at the 3’ end of either BTH_II0309 or BTH_II0311 using the suicide vector pGPΩTp 
to introduce a C-terminal 6His-tag. Cells from 1 litre mid-log phase bacterial cultures were harvested 
by centrifugation and disrupted by sonication. The proteins from the bacterial pellets were applied 
to a His-Selective Nickel affinity gel (Sigma) column and washed with equilibration buffer. Bound His-
tagged proteins were eluted from the column under native conditions using 500 mM imidazole 
elution buffer and separated on a 4-16 % NativePAGE (Novex) gel electrophoresis (6 µg of total 
protein loaded per lane). Proteins were transferred to a PVDF membrane and detected using 1:500 
mouse anti-His polyclonal antibody (Novagen) and 1:1500 goat anti-mouse LI-COR® IRDye 800cw. 
Whilst the individual proteins are both approximately 52 kDa, higher molecular weight oligomeric 
complexes were observed for both proteins. 
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Figure S5. The S1PLs of B. thailandensis contribute to D-erythro-sphingosine resistance. Relevant B. 
thailandensis strains were assessed for sphingosine susceptibility in a saline solution supplemented 
with 25 μM of D-erythro-sphingosine, with percentage bacterial survival calculated relative to a 
saline only control for each strain. Each of the individual S1PL-deficient mutants (BTH_II0309 and 
BTH_II0311) exhibited hypersensitivity to D-erythro-sphingosine relative to wildtype (Wt) B. 
thailandensis E264, a phenotype that was fully restored upon complementation 
(pDA17::BTH309/BTH311). Results shown represent the mean +SEM of three independent 
experiments. * p < 0.05; ** p < 0.01; *** p < 0.0001. 
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Figure S6. Constitutively-expressed GFP protein is only detectable in bacterial lysates. To ensure 
that the observed pH-dependent secretion of S1PL was not an artefact arising from overexpression 
whilst under acid-related stress, proteins from whole-cell lysates and culture supernatant (8 µg of 
total protein loaded per lane) of B. thailandensis expressing pDA17::GFP grown in LB pH 7 or pH 4.5 
were separated by 4-12 % SDS-PAGE, transferred to a nitrocellulose membrane and probed with 
anti-GFP antibody. Irrespective of the pH, GFP was only detected in lysates from cell pellets.  
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Figure S7. The pH-dependent secretion of the Burkholderia S1PLs is independent of the Bsa type III 
secretion system. A B. thailandensis Bsa T3SS mutant was constructed by insertional inactivation of 
bsaZ (BTH_II0839) in order to assess the impact on the acid-induced S1PL secretion. (A) When 
cultured at pH 4.5, secretion of the known T3SS effector BopE was abolished in the bsaZ mutant 
(BTH839), confirming the inactivation of the Bsa secretion system. (B) FLAG-tagged BTH_II0309 or 
BTH_II0311 were expressed in the bsaZ mutant cultured at pH 4.5. Secretion of both proteins was 
still detected, despite the inactivation of the Bsa system. 
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Figure S8. Investigating the localisation of secreted B. thailandensis S1PLs during macrophage 
infection. J774A.1 cells were infected (MOI 50, 2 hours) with B. thailandensis expressing either 
BTH_II0309-FLAG or BTH_II0311-FLAG. Following killing of extracellular bacteria with kanamycin 
(1000 µg ml-1, 2 hours), staining of cellular compartments and anti-FLAG detection was performed. 
Mitochondria were stained with MitoTracker Red-CMXRos, ER with anti-Calnexin, and the cytosolic 
compartment stained with anti-MEK1/2. The B. thailandensis S1PL-FLAG proteins were detected 
with anti-FLAG. For colocalisation presentation clarity, images were convoluted and processed with 
the (default) threshold algorithm of the Fiji software (Schindelin et al., 2012). Colocalisation is shown 
in yellow. Scale bars represent 10 µm. 
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Figure S9. BPSS2025 S1PL is required for  intracellular replication of B. pseudomallei. J774A.1 
macrophages were infected with relevant strains of B. pseudomallei and viable intracellular bacteria 
were quantified at 2 and 6 hpi by spotting serial dilutions of macrophage lysates. For each strain, 
bacterial survival was normalised to the CFU counts observed at 2 hpi and presented as relative 
bacteria survival (%) so as to visualise intracellular replication between 2 and 6 hpi. The S1PL-
deficient mutant (ΔBPSS2025) showed impaired intracellular replication relative to the wildtype, a 
phenotype that was partially restored by complementation. * p<0.01; ** p<0.001; *** p<0.0001. 
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Table S1. List of strains and plasmids used in this study. 
Strains or plasmids Description Reference / Source 
Burkholderia  thailandensis   
      Bth Wt Wildtype B. thailandensis E264 (Brett et al., 1998) 
      BTH_II0309 E264, pGPΩTp::BTH_II0309, TpR This study 
      BTH_II0311 E264, pGPΩTp::BTH_II0311, TpR This study 
      pDA17::BTH_II0309 E264, pGPΩTp::BTH_II0309, pDA17::BTH_II0309, TpR TetR This study 
      pDA17::BTH_II0311 E264, pGPΩTp::BTH_II0309, pDA17::BTH_II0311, TpR TetR This study 
      E264-RFP E264, pBHR4-groS-rfp, CmR This study 
      BTH_II0309-RFP BTH_II0309, pBHR4-groS-rfp, TpR, CmR This study 
      BTH_II0311-RFP BTH_II0311, pBHR4-groS-rfp, TpR, CmR This study 
      BTH_II0309-FLAG E264, pDA17::BTH_II0309-C-terminal FLAG tag, TetR This study 
      BTH_II0311-FLAG E264, pDA17::BTH_II0311-C-terminal FLAG tag, TetR This study 
Burkholderia  pseudomallei   
      Bps Wt Wildtype B. pseudomallei K96243  (Holden et al., 2004) 
      BPSS2025 K96243, ΔBPSS2025 (pDM4 mutagenesis) This study 
      BPSS2025+2021 K96243, ΔBPSS2025, pGPΩTp::BPSS2021, TpR This study 
E.coli         
      TOP10 F− mcrA Δ(mrr-hsdRMS-mcrBC) ϕ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG λ− 
Invitrogen 
       GT115 F− mcrA Δ(mrr-hsdRMS-mcrBC) ϕ80lacZΔM15 ΔlacX74 recA1 rspL 
(StrA) endA1 Δdcm uidA(ΔMluI) : : pir-116 ΔsbcC-sbcD 
Invitrogen 
Saccharomyces cerevisiae    
      BY4741 MATa  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 K. Haynes, Exeter 
      YDR294C BY4741, Δdpl1 K. Haynes, Exeter 
      Wt+ vector BY4741, pDEST413 This study 
      Δdpl1+ vector YDR294C, pDEST413 This study 
      Δdpl1+ dpl1 YDR294C, pDEST413::dpl1 This study 
      Δdpl1+ BTH_II0309 YDR294C, pDEST413::BTH_II0309 This study 
      Δdpl1+ BTH_II0311 YDR294C, pDEST415::BTH_II0311 This study 
      Δdpl1+ BTH_II0309 
   +BTH_II0311 
YDR294C, pDEST413::BTH_II0309, pDEST415::BTH_II0311 This study 
Plasmids         
      pGPΩTp oriR6K, ΩTpR cassette, mob+ (Flannagan et al., 2007) 
      pDM4 oriR6K, sacB CmR (Logue et al., 2009) 
      pRK2013 oricolE1, RK2 derivative, KanR, mob+tra+ (Figurski and Helinski, 1979) 
      pDA17 oripBBR1, TetR, mob+, Pdhfr (Flannagan et al., 2008) 
      pDONR™221 Gateway vector, KanR K. Haynes, Exeter 
      pBHR4-groS-RFP Broad-host range vector containing far-red fluorescent protein 
TurboFP635, CmR 
(Wand et al., 2011) 
      pDEST413 Gateway vector, AmpR, HIS3, CEN ORI ccdB K. Haynes, Exeter 
      pDEST415 Gateway vector, AmpR, LEU2, CEN ORI ccdB K. Haynes, Exeter 
      pDEST413::dpl1 Gateway vector, AmpR, HIS3, CEN ORI ccdB, dpl1 This study 
      pDEST413::BTH_II0309 Gateway vector, AmpR, HIS3, CEN ORI ccdB, BTH_II0309 This study 
      pDEST415::BTH_II0311 Gateway vector, AmpR, LEU2, CEN ORI ccdB, BTH_II0311 This study 
Resistance determinants: TetR, Tetracycline; TpR, Trimethoprim; CmR, Chloramphenicol; AmpR, Ampicillin; KanR, Kanamycin. 
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